Friday, October 24, 2025

Latest

Tetra Bio Pharma To Conduct $10 Million Bought Deal Financing

Tetra Bio Pharma (TSXV: TBP) this morning announced that it will be conducting a financing for up to $10 million following the recent announcement of acquiring Health Canada approval for two of its products. The financing, which is being conducted on a bought deal basis, is being ran through that of Echelon Wealth Partners.

Gross proceeds for the financing are expected to be approximately $10.0 million, with Echelon having the option for a 15% over allotment dependent on investor demand. The financing is being conducted at a price per unit of $0.53, with each unit also including a full warrant exercisable for a period of three years at a price of $0.75 each.

Proceeds from the financing will be utilized for working capital and general corporate purposes. While not explicitly stated, the funds will likely go towards Tetra Bio Pharma’s recently announced commercialization strategy for that of its Terpacan products, which last week received approval for over the counter sales by Health Canada. The current strategy outlines an estimated commercialization date of mid 2020.

The financing is expected to close on or around February 13, 2020.

Tetra Bio Pharma last traded at $0.62 on the TSX Venture.


Information for this briefing was found via Sedar, Health Canada and Tetra Bio-Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Tetra Bio Pharma Sees Two Products Approved By Health Canada

As The Deep Dive reported on late yesterday afternoon, Tetra Bio Pharma (TSXV: TBP) has...

Friday, January 17, 2020, 09:31:54 AM

Tetra Bio Pharma Sees Product Approved For FDA Fast Track Designation Request

Tetra Bio-Pharma (TSXV: TBP) has received a much anticipated response from the US Food and...

Monday, February 3, 2020, 08:47:08 AM

Drug Trade: The Three Basic Cannabis Health Company Archetypes

The popular belief that cannabis will work its way further into mainstream culture and further...

Saturday, December 21, 2019, 08:00:00 AM

Tetra Bio-Pharma Subsidiary Conducts Financing for Hemp Energy Drink

Tetra Bio-Pharma (TSXV: TBP) announced this morning that a subsidiary of the firm has obtained...

Monday, November 18, 2019, 08:54:24 AM

Tetra Bio-Pharma Issues Operational Update Regarding COVID-19

Tetra Bio-Pharma Inc (TSXV: TBP) has issued an update regarding the working conditions for its...

Tuesday, March 24, 2020, 08:05:00 AM